These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2869507)

  • 41. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absorption and bioavailability of pentaerithrityl-tetranitrate (PETN, Dilcoran 80).
    Haustein KO; Winkler U; Löffler A; Hüller G
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):95-102. PubMed ID: 7757318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single dose absorption profiles and bioavailability of two different salbutamol tablets.
    Jonkman JH; Freie HM; van der Boon WJ; Grasmeijer G
    Arzneimittelforschung; 1986 Jul; 36(7):1133-5. PubMed ID: 3768084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
    Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
    Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioavailability of indomethacin tablets in men volunteers.
    Groth PE; Dunn JM
    Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA; Taggart WV
    Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
    J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bioavailability of two slow-release formulations of verapamil].
    Keller-Stanislawski B; Rietbrock N
    Arzneimittelforschung; 1990 Oct; 40(10):1086-8. PubMed ID: 2291745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood levels and bioavailability of ascorbic acid after administration of a sustained-release formulation to humans.
    Sacharin R; Taylor T; Chasseaud LF
    Int J Vitam Nutr Res; 1977; 47(1):68-74. PubMed ID: 844951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Biological availability of potassium from a sustained release preparation].
    Müller A; Thoma M; Renker H
    Schweiz Med Wochenschr; 1976 Jan; 106(1):27-30. PubMed ID: 1251146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation of orally fast-dissolving tablets of etilefrine hydrochloride to achieve efficient absorption.
    Sakata O; Onishi H
    Pharm Dev Technol; 2020 Nov; 25(9):1162-1167. PubMed ID: 32644855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absorption of sustained-release and plain papaverine in man.
    Kanto J; Iisalo E; Manell D; Mäntylä R
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):375-7. PubMed ID: 500258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absorption behavior of etilefrine after buccal administration in rats.
    Onishi H; Sakata O
    Int J Pharm; 2018 Oct; 550(1-2):14-23. PubMed ID: 30107221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-performance liquid chromatographic determination of etilefrine in human plasma using combined solid-phase and organic solvent extraction and electrochemical detection.
    Kojima K; Yamanaka M; Nakanishi Y; Arakawa S
    J Chromatogr; 1990 Jan; 525(1):210-7. PubMed ID: 1970985
    [No Abstract]   [Full Text] [Related]  

  • 60. The cardiovascular effects of etilefrine.
    Coleman AJ; Leary WP; Asmal AC
    Eur J Clin Pharmacol; 1975; 8(1):41-5. PubMed ID: 9293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.